Clinical Nutrition Open Science,
Journal Year:
2024,
Volume and Issue:
57, P. 78 - 87
Published: July 16, 2024
SARS-CoV-2
has
had
a
significant
worldwide
impact,
leading
to
widespread
illness
and
mortality.
With
the
lack
of
specific
antiviral
treatments,
there
is
growing
interest
in
exploring
potential
therapeutic
effects
various
nutritional
supplements,
including
vitamin
D.
Vitamin
D
plays
an
essential
role
health,
been
implicated
modulating
immune
response
reducing
inflammation,
which
may
have
implications
prevention
management
coronavirus
disease
2019
(COVID-19).
Patients
having
low
level
are
predisposed
severe
consequences.
COVID-19
shown
inverse
relationship.
This
review
understanding
remedial
COVID-19,
its
mechanism
action,
evidence
from
clinical
studies,
recommendations
for
supplementation
patients
suffering
COVID-19.Material
MethodsGoogle
scholar,
Sci-Hub,
pubmed.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(9), P. 1509 - 1509
Published: Sept. 21, 2023
COVID-19
vaccines
were
developed
at
an
unprecedented
speed
in
history.
The
factors
affecting
the
response
to
are
not
clear.
Herein,
effects
of
vitamin
D
and
A
(retinol)
levels
on
BNT162b2
vaccine
explored.
total
124
recipients
recruited
from
general
population
attending
vaccination
centers
Irbid,
Jordan.
Blood
samples
collected
immediately
before
receiving
first
dose
(D0)
three
weeks
later
(D21).
Baseline
25-hydroxyvitamin
[25(OH)D],
retinol,
SARS-CoV-2
S1
IgG
antibodies
measured
with
ELISA.
was
tested
by
measuring
avidity
D21.
participants
divided
into
two
groups,
unexposed
exposed,
based
D0
antibody
results.
No
significant
correlation
found
between
25(OH)D
or
retinol
levels,
avidity,
fold
increase
both
groups.
Similarly,
no
difference
status
combined
These
findings
show
that
baseline
have
effect
short-term
a
single
vaccine.
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Nov. 25, 2024
Objectives
Vitamin
D
has
a
role
in
the
innate
immunity
against
pathogens
and
is
also
involved
mechanisms
for
reducing
inflammation.
VD
deficiency
(VDD)
may
increase
COVID-19
infection
susceptibility,
however
research
limited
on
association
between
VDD
symptom
prevalence
duration.
The
study
aimed
to
determine
whether
risk
factor
presence
extended
duration
of
symptoms.
Methods
Data
was
analyzed
from
NHS
healthcare
workers
who
isolated
due
symptoms
as
part
convalescent
12th
22nd
May
2020.
Participants
self-reported
viral
Anti-SARS-CoV-2
antibodies
vitamin
(25(OH)D
3
)
serum
levels
were
measured
day
recruitment.
defined
25(OH)D
<
30
nmol/l.
Results
Of
392
participants,
15.6%
(
n
=
61)
had
VDD.
participants
more
overall
p
0.0030),
including
body
aches
0.0453),
0.0075)
fatigue
0.0127).
Binary
logistic
regression
found
that
both
(OR
3.069,
95%
CI
1.538–6.124;
0.001)
age
1.026,
1.003–1.049;
0.025)
independently
associated
with
durations
aches.
2.089,
1.087–4.011;
0.027),
1.036,
1.016–1.057;
seroconversion
1.917,
1.203–3.056;
0.006),
fatigue.
Conclusion
significant
independent
supplementation
reduce
thus
an
area
future
research.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(1), P. 98 - 98
Published: Jan. 18, 2024
With
the
worldwide
spread
of
SARS-CoV-2
disease,
people
with
cystic
fibrosis
(CF),
especially
solid
organ
transplant
recipients,
have
quickly
been
identified
as
a
risk
group
for
severe
disease.
Studies
shown
low
antibody
response
to
vaccines
in
recipients
compared
healthy
population.
Information
on
immune
CF
patients
transplantation
is
limited,
regarding
long-term
efficacy.
The
aim
this
real-world
study
was
assessment
humoral
induced
by
three
and
four
doses
mRNA
vaccine.
S1RBD
IgG
antibodies
were
measured
every
12
weeks
over
period
27
months
twelve
(five
liver
seven
lung
recipients).
A
total
83.3%
our
showed
positive
after
sustained
observed
both
groups
observation
period,
showing
higher
levels
than
recipients.
This
among
first
show
data
constantly
elevated
or
even
increasing
levels.
We
conclude
that
effect
most
likely
associated
repeated
boostering
terms
infections
booster
vaccinations.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(2), P. 121 - 121
Published: Jan. 24, 2024
Background:
Structural
and
functional
commonalities
between
poliovirus
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
suggest
that
inoculation
may
induce
antibodies
mitigate
the
disease
(COVID-19).
No
known
studies
have
evaluated
COVID-19
risk
factors
in
adults
recently
vaccinated
against
poliovirus.
Study
Objective:
Among
with
no
history
of
infection
or
vaccination,
who
received
an
inactivated
vaccine
(IPV),
we
sought
to
determine
which
biological
social
determinants
health
(SDOH)
be
associated
(1)
testing
positive
for
SARS-CoV-2,
(2)
experiencing
symptoms,
(3)
a
longer
duration
symptoms.
Methods:
The
influence
SDOH
on
SARS-CoV-2
symptoms
were
among
282
inoculated
IPV.
Participant-reported
surveys
analyzed
over
12
months
post-enrollment.
Bivariate
multivariate
linear
logistic
regression
models
identified
associations
variables
outcomes.
Results:
Adjusting
vaccinations,
variants,
other
SDOH,
secondary
analyses
revealed
underlying
conditions,
employment,
vitamin
D,
education,
oral
vaccination
(OPV)
odds
significantly
reduced
participants
took
D
(OR
0.12
OR
0.09,
respectively).
Unemployed
part-time
working
72%
less
likely
test
compared
full-time
workers.
prior
dose
OPV
was
one
strongest
predictors
4.36)
6.95).
Conclusions:
Findings
prophylactic
measures
mucosal
immunity
severity
Larger-scale
inform
future
policies.
F1000Research,
Journal Year:
2024,
Volume and Issue:
12, P. 394 - 394
Published: Feb. 5, 2024
Background
Vitamin
D
deficiency
is
an
emerging
public
health
problem
that
affects
more
than
one
billion
people
worldwide.
has
been
shown
to
be
effective
in
preventing
and
reducing
the
severity
of
viral
respiratory
diseases,
including
influenza.
However,
role
vitamin
COVID-19
infection
remains
controversial.
This
study
aimed
analyze
association
on
clinical
outcome
hospitalized
patients.
Methods
A
prospective
cohort
was
conducted
among
patients
at
two
referral
hospitals
Indonesia
from
October
2021
until
February
2022.
Results
The
median
serum
25(OH)D
level
191
13.6
[IQR=10.98]
ng/mL.
levels
were
significantly
lower
with
who
had
cardiovascular
disease
(p-value=0.04),
use
a
ventilator
(p-value=0.004),
severe
cases
(p-value=0.047),
mortality
(p-value=0.002).
Furthermore,
different
between
mild
(p-value=0.019).
Serum
moderate
(p-value=0.031).
Lower
associated
increased
number
comorbidities
(p-value=0.03),
(p-value=0.002),
mechanical
ventilation
(p-value=0.032).
Mortality
found
7.3%
deficient
levels.
either
sufficient
or
insufficient
did
not
develop
mortality.
Conclusions
having
disease,
mortality,
cases,
used
ventilation.
comorbidities,
severity,
mechanical-ventilation.
Thus,
we
suggest
reach
status
improve
disease.
Clinical Nutrition Open Science,
Journal Year:
2024,
Volume and Issue:
57, P. 78 - 87
Published: July 16, 2024
SARS-CoV-2
has
had
a
significant
worldwide
impact,
leading
to
widespread
illness
and
mortality.
With
the
lack
of
specific
antiviral
treatments,
there
is
growing
interest
in
exploring
potential
therapeutic
effects
various
nutritional
supplements,
including
vitamin
D.
Vitamin
D
plays
an
essential
role
health,
been
implicated
modulating
immune
response
reducing
inflammation,
which
may
have
implications
prevention
management
coronavirus
disease
2019
(COVID-19).
Patients
having
low
level
are
predisposed
severe
consequences.
COVID-19
shown
inverse
relationship.
This
review
understanding
remedial
COVID-19,
its
mechanism
action,
evidence
from
clinical
studies,
recommendations
for
supplementation
patients
suffering
COVID-19.Material
MethodsGoogle
scholar,
Sci-Hub,
pubmed.